Global Newswire by Notified: M&A

JULY 28, 2023

Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3

Pharmaceutical 76

Pharmaceutical Shares 76

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

MAY 10, 2024

Nika Pharmaceuticals, Inc. NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

MARCH 21, 2024

March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. DEER PARK, Ill.,

Pharmaceutical 45

Pharmaceutical Acquisitions IT 45

PE Hub

SEPTEMBER 22, 2023

The post Gurnet Point and Novo Holdings complete take-private buyout of Paratek Pharmaceuticals appeared first on PE Hub. The purchase price is about $462 million.

Pharmaceutical 79

Pharmaceutical 79

Global Newswire by Notified: M&A

MAY 6, 2024

Lophos", or the "Company") (CSE:MESC) is pleased to announce that its wholly-owned subsidiary, Lophos Pharmaceuticals Corp. NAPANEE, Ontario, May 06, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc.

Pharmaceutical 45

Pharmaceutical Sale Business IT 45

JD Supra: Mergers

MAY 15, 2024

Bass, Berry & Sims brought a team of four attorneys from our Specialty Pharmacy & Pharmaceuticals and 340B Program Services practice groups to join the fun. Asembia’s 20th Annual Specialty Pharmacy Summit once again brought investors and operators in the specialty pharmacy ecosystem to Las Vegas for learning sessions and networking.

Pharmaceutical 170

Pharmaceutical Investors 170

PE Hub

JUNE 6, 2023

The post Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m appeared first on PE Hub. Oaktree Capital Management will provide $175 million in debt financing for this deal.

Pharmaceutical 74

Pharmaceutical Debt Finance Finance 74

JD Supra: Mergers

APRIL 18, 2024

On March 26, 2024, Skadden hosted a discussion on key developments in antitrust enforcement in the pharmaceuticals and life sciences sectors. By: Skadden, Arps, Slate, Meagher & Flom LLP

Pharmaceutical 170

Pharmaceutical 170

PE Hub

NOVEMBER 14, 2023

The post Nordic Capital bets it can help the pharmaceutical industry speed up technology adoption appeared first on PE Hub. Nordic is acquiring the majority stake in IntegriChain, a Philadelphia-based provider of technology for the life sciences industry, from Accel-KKR.

Pharmaceutical 65

Pharmaceutical Capital IT 65

Global Newswire by Notified: M&A

DECEMBER 4, 2023

Rising demand for functional excipients and oral pharmaceutical medicines and increasing number of pharmaceuticals industries across the globe are key factors driving Pharmaceutical Excipients market revenue growth.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

MARCH 11, 2024

SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. Nasdaq: CDT ) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory space in Cambridge, United Kingdom, a global centre for research and development for companies at the forefront of life science innovation.

Pharmaceutical 45

Pharmaceutical Portfolio Acquisitions 45

Global Newswire by Notified: M&A

JANUARY 4, 2024

Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (API) market revenue growth Rising demand for pharmaceutical drugs and increasing drug Research & Development (R&D) activities are key factors driving Active Pharmaceutical Ingredients (..)

Pharmaceutical 40

Pharmaceutical 40

Global Banking & Finance

MARCH 5, 2024

Active Pharmaceutical Ingredients Market to hit $ 372.6 billion by 2030: Verified Market Reports The Global Active Pharmaceutical Ingredients Market size was valued at USD 237.3 Billion in 2023 and is expected to reach USD 372.6 Billion by the end of 2030 with a CAGR of 6.9% During the Forecast Period 2023-2030.

Pharmaceutical 40

Pharmaceutical 40

Global Newswire by Notified: M&A

APRIL 15, 2024

Nika Pharmaceuticals, Inc. NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one dietary supplement.

Pharmaceutical 45

Pharmaceutical 45

Global Newswire by Notified: M&A

JANUARY 2, 2024

The global Pharmaceutical Packaging market size is expected to reach USD 249.41 Additionally, the rise in generic drug manufacturing, advancements in pharmaceutical technologies, and the push for sustainable and eco-friendly packaging options are also contributing factors fueling the market's growth.

Pharmaceutical 40

Pharmaceutical Healthcare Manufacturing 40

Global Newswire by Notified: M&A

AUGUST 3, 2023

SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 SkyQuest projects that the pharmaceutical contract development and manufacturing market will attain a value of USD 222.87 billion by 2030, with a CAGR of 6.9% over the forecast period (2023-2030).

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Global Newswire by Notified: M&A

MAY 1, 2024

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries.

Pharmaceutical 40

Pharmaceutical Shares Acquisitions 40

Global Newswire by Notified: M&A

JANUARY 31, 2024

The global Pharmaceutical Analytical Testing Outsourcing market size is expected to reach USD 15.09 The global Pharmaceutical Analytical Testing Outsourcing market size is expected to reach USD 15.09 billion by 2030 and exhibit a CAGR of 8.4% in the forecast period (2023−2030), according to Skyquest's latest research report.

Pharmaceutical 40

Pharmaceutical 40

JD Supra: Mergers

MARCH 27, 2024

designs and produces solutions for the biopharmaceutical, pharmaceutical and medical device markets and aerospace industries. New Mountain Capital will sell ILC Dover to Ingersoll Rand for about $2.3 billion, according to industry reports. ILC, founded in 1947 and based in Frederica, Del., By: McGuireWoods LLP

Private Equity 154

Private Equity Pharmaceutical Healthcare Medical 154

Global Newswire by Notified: M&A

SEPTEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp., SAN DIEGO, Sept.

Pharmaceutical 40

Pharmaceutical Acquisitions Business 40

Global Newswire by Notified: M&A

JULY 13, 2023

West Conshohocken, PA, July 13, 2023 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today that it has acquired two life-saving medicines, Vistogard ® (uridine triacetate) and Xuriden ® (uridine triacetate), from Wellstat Therapeutics.

Pharmaceutical 40

Pharmaceutical IT 40

JD Supra: Mergers

APRIL 23, 2024

We were fortunate to have a mix of expert perspectives at the table, representing large pharmaceutical companies, investors, By: Mintz Asset Sale,” with business development leaders from GSK, Johnson & Johnson, Locust Walk, and Astria Therapeutics.

Pharmaceutical 165

Pharmaceutical M&A Sale Investors 165

Global Newswire by Notified: M&A

FEBRUARY 16, 2024

The rising demand for succinic Acid (SA) can be attributed to its expanding utility in pharmaceutical manufacturing and its pivotal role in building and infrastructure development operations in the global succinic acid market. SkyQuest projects that the global succinic acid market will attain a value of USD 562.57

Utilities 40

Utilities Pharmaceutical Manufacturing IT 40

Global Newswire by Notified: M&A

AUGUST 4, 2023

SkyQuest projects that the pharmaceutical processing equipment market will attain a value of USD 15.71 The growth of the pharmaceutical processing equipment market can be attributed to several factors. SkyQuest projects that the pharmaceutical processing equipment market will attain a value of USD 15.71

Pharmaceutical 40

Pharmaceutical Manufacturing 40

Global Newswire by Notified: M&A

MARCH 27, 2024

VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has closed on its agreement with Seyltx Inc.

Pharmaceutical 40

Pharmaceutical Equities Acquisitions IT 40

Global Newswire by Notified: M&A

SEPTEMBER 29, 2023

29, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today released the following letter to stockholders concerning the pending tender offer by Harmony Biosciences Holdings, Inc.

Pharmaceutical 45

Pharmaceutical Shares 45

Global Newswire by Notified: M&A

AUGUST 16, 2023

Rising use of drugs in the form of capsules and other forms of medication on a global scale is a key factor driving pharmaceutical packaging market revenue growth. Rising use of drugs in the form of capsules and other forms of medication on a global scale is a key factor driving pharmaceutical packaging market revenue growth.

Pharmaceutical 40

Pharmaceutical Medical 40

Global Newswire by Notified: M&A

JULY 18, 2023

TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company” or “Polydex”) held a Special Meeting on July 14, 2023 relating to a Plan of Arrangement involving Polydex Pharmaceuticals Limited, Biospectra International Inc., and Biospectra Canada Inc.,

Pharmaceutical 40

Pharmaceutical Business Shares 40

Global Newswire by Notified: M&A

JUNE 27, 2023

BOSTON, June 27, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. together with its affiliates (collectively, "NexPoint").

Pharmaceutical 40

Pharmaceutical Asset Management Management IT 40

Global Newswire by Notified: M&A

AUGUST 3, 2023

03, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, today announced the closing of a $115 million loan facility with Hercules Capital, Inc. BOSTON, Aug. NYSE: HTGC) (“Hercules”).

Pharmaceutical 40

Pharmaceutical Capital IT 40

Global Newswire by Notified: M&A

NOVEMBER 22, 2023

22, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has signed a Letter of Intent (“LOI”) with Seyltx Inc. VANCOUVER, British Columbia, Nov.

Pharmaceutical 49

Pharmaceutical Equities IT Negotiation 49

Global Newswire by Notified: M&A

AUGUST 9, 2023

09, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company” or “Polydex”) announced today that it has consummated the Plan of Arrangement (the “Arrangement”) whereby BioSpectra, Inc. TORONTO, Aug. was paid for 3,432,478 common shares outstanding and US$15,019.98

Pharmaceutical 40

Pharmaceutical Business Shares IT 40

JD Supra: Mergers

JANUARY 22, 2024

Morgan Healthcare Conference in San Francisco, which also saw the announcement of major acquisitions by large players in the pharmaceutical space. The timing of the announcement coincided with the start of the 42nd Annual J.P. By: Knobbe Martens

Pharmaceutical 175

Pharmaceutical Healthcare Corporation Equities 175

JD Supra: Mergers

JANUARY 26, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022), total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. By: Cooley LLP

M&A 165

M&A Pharmaceutical Business 165

JD Supra: Mergers

JULY 24, 2023

While the two companies evidently have some history together, this new deal is reportedly tied to Phillip Morris’ interest in acquiring Syqe’s metered-dose, pharmaceutical-grade inhaler that dispenses precise doses of medical cannabis to patients. By: Bradley Arant Boult Cummings LLP

Medical 246

Medical Pharmaceutical 246

Global Newswire by Notified: M&A

MAY 13, 2024

Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing OnKure’s portfolio of novel precision medicines in oncology

Mergers 53

Mergers Pharmaceutical Portfolio 53